長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4538】扶桑薬品工業

【4538】扶桑薬品工業
人工腎臓用透析剤・補液。
類似企業：


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/11 Q2予 60,000 ↑ +5.3% +5.3% 4,000 ↑ +53.8% +53.8% 3,700 ↑ +60.9% +60.9% 2,600 ↑ +52.9% +52.9%
2025.03 2024/08/08 Q1予 57,000 → 0.0% 0.0% 2,600 → 0.0% 0.0% 2,300 → 0.0% 0.0% 1,700 → 0.0% 0.0%
2025.03 2024/05/10 当初予 57,000 - - - 2,600 - - - 2,300 - - - 1,700 - - -
2024.03 2024/05/10 実 55,407 ↑ +4.0% +4.0% 1,964 ↓ -1.8% -1.8% 1,868 ↓ -6.6% -6.6% 1,377 ↑ +5.9% +5.9%
2024.03 2024/02/13 Q3予 53,300 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,300 → 0.0% 0.0%
2024.03 2023/11/10 Q2予 53,300 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,300 → 0.0% 0.0%
2024.03 2023/08/09 Q1予 53,300 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,300 → 0.0% 0.0%
2024.03 2023/05/10 当初予 53,300 - - - 2,000 - - - 2,000 - - - 1,300 - - -
2023.03 2023/05/10 実 51,015 ↑ +2.0% +2.0% 2,206 ↑ +16.1% +37.9% 2,215 ↑ +16.6% +38.4% 1,605 ↑ +14.6% +45.9%
2023.03 2023/02/10 Q3予 50,000 → 0.0% 0.0% 1,900 → 0.0% +18.8% 1,900 → 0.0% +18.8% 1,400 → 0.0% +27.3%
2023.03 2022/11/09 Q2予 50,000 → 0.0% 0.0% 1,900 ↑ +18.8% +18.8% 1,900 ↑ +18.8% +18.8% 1,400 ↑ +27.3% +27.3%
2023.03 2022/08/09 Q1予 50,000 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,100 → 0.0% 0.0%
2023.03 2022/05/11 当初予 50,000 - - - 1,600 - - - 1,600 - - - 1,100 - - -
2022.03 2022/05/11 実 49,632 ↑ +0.9% +2.3% 1,924 ↑ +20.2% +60.3% 1,996 ↑ +24.8% +81.5% 1,483 ↑ +23.6% +111.9%
2022.03 2022/02/09 Q3予 49,200 → 0.0% +1.4% 1,600 → 0.0% +33.3% 1,600 → 0.0% +45.5% 1,200 → 0.0% +71.4%
2022.03 2021/11/11 Q2予 49,200 ↑ +1.4% +1.4% 1,600 ↑ +33.3% +33.3% 1,600 ↑ +45.5% +45.5% 1,200 ↑ +71.4% +71.4%
2022.03 2021/08/11 Q1予 48,500 → 0.0% 0.0% 1,200 → 0.0% 0.0% 1,100 → 0.0% 0.0% 700 → 0.0% 0.0%
2022.03 2021/05/12 当初予 48,500 - - - 1,200 - - - 1,100 - - - 700 - - -
2021.03 2021/05/12 実 49,251 ↑ +0.1% +0.9% 2,351 ↓ -16.0% +46.9% 2,227 ↓ -14.3% +48.5% 1,607 ↓ -15.4% +46.1%
2021.03 2021/02/09 Q3予 49,200 → 0.0% +0.8% 2,800 → 0.0% +75.0% 2,600 → 0.0% +73.3% 1,900 → 0.0% +72.7%
2021.03 2020/11/10 Q2予 49,200 ↑ +0.8% +0.8% 2,800 ↑ +75.0% +75.0% 2,600 ↑ +73.3% +73.3% 1,900 ↑ +72.7% +72.7%
2021.03 2020/08/11 Q1予 48,800 → 0.0% 0.0% 1,600 → 0.0% 0.0% 1,500 → 0.0% 0.0% 1,100 → 0.0% 0.0%
2021.03 2020/05/12 当初予 48,800 - - - 1,600 - - - 1,500 - - - 1,100 - - -
2020.03 2020/05/12 実 46,902 ↑ +0.0% +1.5% 1,010 ↑ +1.0% +55.4% 1,066 ↑ +0.6% +77.7% 707 ↑ +1.0% +76.8%
2020.03 2020/05/07 修正予 46,900 ↑ +1.5% +1.5% 1,000 ↑ +53.8% +53.8% 1,060 ↑ +76.7% +76.7% 700 ↑ +75.0% +75.0%
2020.03 2020/02/10 Q3予 46,200 → 0.0% 0.0% 650 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0%
2020.03 2019/11/08 Q2予 46,200 → 0.0% 0.0% 650 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0%
2020.03 2019/08/08 Q1予 46,200 → 0.0% 0.0% 650 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0%
2020.03 2019/05/10 当初予 46,200 - - - 650 - - - 600 - - - 400 - - -
2019.03 2019/05/10 実 46,074 ↓ -0.3% -0.3% 1,261 ↑ +26.1% +26.1% 1,279 ↑ +42.1% +42.1% 894 ↑ +49.0% +49.0%
2019.03 2019/02/08 Q3予 46,200 → 0.0% 0.0% 1,000 → 0.0% 0.0% 900 → 0.0% 0.0% 600 → 0.0% 0.0%
2019.03 2018/11/07 Q2予 46,200 → 0.0% 0.0% 1,000 → 0.0% 0.0% 900 → 0.0% 0.0% 600 → 0.0% 0.0%
2019.03 2018/08/08 Q1予 46,200 → 0.0% 0.0% 1,000 - - - 900 → 0.0% 0.0% 600 → 0.0% 0.0%
2019.03 2018/05/10 当初予 46,200 - - - - - - - 900 - - - 600 - - -
2018.03 2018/05/10 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/08 Q3予 47,300 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 1,000 → 0.0% +66.7%
2018.03 2017/11/08 修正予 47,300 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 1,000 ↑ +66.7% +66.7%
2018.03 2017/08/08 Q1予 47,300 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 600 → 0.0% 0.0%
2018.03 2017/05/11 当初予 47,300 - - - 800 - - - 800 - - - 600 - - -
2017.03 2017/05/11 実 46,782 ↓ -0.5% -0.5% 656 ↓ -27.1% -53.1% 642 ↓ -24.5% -46.5% 861 ↓ -4.3% +7.6%
2017.03 2017/02/08 Q3予 47,000 → 0.0% 0.0% 900 ↓ -35.7% -35.7% 850 ↓ -29.2% -29.2% 900 ↑ +12.5% +12.5%
2017.03 2016/05/10 当初予 47,000 - - - 1,400 - - - 1,200 - - - 800 - - -
2016.03 2016/05/10 実 45,752 ↓ -0.5% -0.5% 296 ↓ -50.7% -50.7% 172 ↓ -57.0% -57.0% 10 ↓ -96.7% -96.7%
2016.03 2016/02/05 Q3予 46,000 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0% 300 → 0.0% 0.0%
2016.03 2015/11/06 Q2予 46,000 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0% 300 → 0.0% 0.0%
2016.03 2015/08/07 Q1予 46,000 → 0.0% 0.0% 600 - - - 400 → 0.0% 0.0% 300 → 0.0% 0.0%
2016.03 2015/05/08 当初予 46,000 - - - - - - - 400 - - - 300 - - -
2015.03 2015/05/08 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/06 Q3予 47,600 → 0.0% -2.5% 600 → 0.0% -60.0% 500 → 0.0% -64.3% 350 → 0.0% -61.1%
2015.03 2014/11/07 Q2予 47,600 ↓ -2.5% -2.5% 600 ↓ -60.0% -60.0% 500 ↓ -64.3% -64.3% 350 ↓ -61.1% -61.1%
2015.03 2014/08/08 Q1予 48,800 → 0.0% 0.0% - - - - 1,400 → 0.0% 0.0% 900 → 0.0% 0.0%
2015.03 2014/05/09 当初予 48,800 - - - 1,500 - - - 1,400 - - - 900 - - -
2014.03 2014/05/09 実 49,098 - - - 2,797 - - - 2,741 - - - 1,979 - - -
シェア ツイート
ページトップへ戻る